Leaflet BUPRENORFINA ALKALOID 8mg sublingual tablets
Indicated for: severe pain; opioid dependence
Route of administration: sublingual
Substance: buprenorphine (opioid analgesic)
ATC: N07BC01 (Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may cause dependence or be misused.
May slow breathing, especially with alcohol or sedatives.
Avoid alcohol during treatment.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Older people may have an increased risk of side effects.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
Buprenorphine is an opioid analgesic used for the treatment of moderate to severe pain and for managing opioid dependence. It is a partial agonist of mu-opioid receptors and an antagonist of kappa-opioid receptors, providing strong analgesic effects with a lower risk of respiratory depression compared to other opioids.
The medication is available in the form of sublingual tablets, transdermal patches, or injections, and the dosage is adjusted based on the severity of pain or the patient's needs in opioid dependence treatment.
Common side effects include nausea, constipation, dizziness, drowsiness, and excessive sweating. In rare cases, more severe adverse effects such as severe respiratory depression or allergic reactions may occur.
Buprenorphine is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, the use of this medication requires careful medical supervision to prevent abuse, dependence, or other complications associated with opioids.
General data about BUPRENORFINA ALKALOID 8mg
- Substance: buprenorphine
- Date of last drug list: 01-03-2026
- Commercial code: W58841002
- Concentration: 8mg
- Pharmaceutical form: sublingual tablets
- Quantity: 28
- Product type: generic
- Prescription restrictions: TAB3 - Medicines that are issued with a special prescription (psychotropic) in green color.
Pharmaceutical forms available for buprenorphine
Concentrations available for buprenorphine
- 0.4mg
- 2mg
- 35mcg/h
- 52.5mcg/h
- 70mcg/h
- 74.2mg
- 8mg